Public-registry site landscape for NCT04681131, a Non-Small-Cell Lung Cancer study sponsored by BioAtla, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04681131 (registry record) |
| Sponsor | BioAtla, Inc. |
| Condition(s) | Non-Small-Cell Lung Cancer |
| Phase | PHASE2 |
| Listed sites | 60 |
| Site countries | United States, Greece, Hong Kong, Italy, Poland, Spain, Taiwan |
Eichor generates a preliminary site-risk snapshot for NCT04681131 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →